News and Trends 1 Sep 2022
Sanofi’s first treatment in the U.S. approved for adults and children with ASMD
A rare, inherited disease that affects the body's ability to metabolize fat, cholesterol and lipids within cells can now be treated by Xenpozyme, a drug approved by the U.S. Food…